Fibroblast Growth Factor Receptors (FGFR), a family of four tyrosine kinase receptors (FGFR1-4), have emerged as potential cancer targets, since FGFR alterations (gene amplifications, mutations, rearrangements/fusions) contribute to tumour development and progression. Here, FGFR1 is linked to neoplasm.